http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110201689-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J27-1817
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-50
filingDate 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110201689-B
titleOfInvention Silk fibroin/silver phosphate nanowire composite pore bracket, construction method and application
abstract The invention discloses a silk fibroin/silver phosphate nanowire composite pore bracket, a construction method and application, comprising the following steps: mixing a silk fibroin solution with the mass percentage concentration of 3-4% with a silver nitrate solution with the mass percentage concentration of 0.5-4% to obtain a mixed solution; freezing the mixed solution, and then drying at low temperature to obtain the silk fibroin oriented pore channel scaffold; adding PAA with the mass volume ratio of 0.15-0.25 mg/ml into a phosphoric acid solution to prepare a reaction solution, placing the silk fibroin oriented pore canal stent into the reaction solution, and reacting for 0.1-4 hours to obtain a reaction product; the silk fibroin/silver phosphate nanowire composite pore bracket can be used as a carrier of a silver phosphate nanomaterial, and in the preparation process, preparation parameters can be regulated and controlled according to the reaction process to regulate and control the appearance and density of the in-situ grown silver phosphate nanocrystal.
priorityDate 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010060437-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452754495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448774721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159913

Total number of triples: 24.